Staphylococcus aureus resistance. now vancomycin
Gobernado, M.
Revista Espanola de Quimioterapia Publicacion Oficial de la Sociedad Espanola de Quimioterapia 15(3): 211-214
2002
ISSN/ISBN: 0214-3429 PMID: 12582424 Document Number: 541202
Document emailed within 1 workday
Related Documents
Filice, G.; Lanzarini, P.; Orsolini, P.; Soldini, L.; Perversi, L.; Carnevale, G.; Comolli, G.; Castelli, F. 1990: Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure Microbiologica 13(3): 231-237Młynarczyk, G.; Młynarczyk, A.; Meisel-Mikołajczyk, F. 1995: Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin Medycyna Doswiadczalna i Mikrobiologia 47(3-4): 133-139
Yourassowsky, E.; Schoutens, E. 1971: Sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin, gentamicin and pristinamycin Acta Clinica Belgica 26(3): 139-145
Panomket, P.; Thirat, S.; Wanram, S.; Sranujit, R.P. 2014: Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Sanprasitthiprasong Hospital Journal of the Medical Association of Thailand 97(Suppl 4): S7-11
Haruta, T.; Okura, K.; Kuroki, S.; Nigami, H.; Kobayashi, Y. 1993: Transferability of vancomycin to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus Japanese Journal of Antibiotics 46(2): 154-158
1997: From the Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997 JAMA 278(11): 891-892
Deguchi, K.; Yokota, N.; Koguchi, M.; Suzuki, Y.; Fukayama, S.; Ishihara, R.; Oda, S. 1993: Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus Japanese Journal of Antibiotics 46(11): 939-945
Deguchi, K.; Yokota, N.; Koguchi, M.; Suzuki, Y.; Fukayama, S.; Ishihara, R.; Oda, S. 1993: Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus Japanese Journal of Antibiotics 46(11): 939-945
Hanaki, H.; Labischinski, H.; Inaba, Y.; Hiramatsu, K. 1998: Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50 Japanese Journal of Antibiotics 51(4): 272-280
Ortega, M.; Marco, F.; Soriano, A.; Almela, M.; Martínez, J.A.; Muñoz, A.; Mensa, J. 2008: Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 21(2): 93-98
Mortlock, S. 2006: Microorganisms mistaken as vancomycin-resistant Staphylococcus aureus at a cancer hospital in Lahore, Pakistan: their true identity revealed British Journal of Biomedical Science 63(1): 21-22
Entenza, J.M.; Vouillamoz, J.; Glauser, M.P.; Moreillon, P. 1997: Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy 41(8): 1662-1667
Gómez-Lus, M.L.; Prieto, J.; Giménez, M.J.; García, M.; Anta, L.; Aguilar, L. 1999: In vitro bactericidal activity of peak serum concentrations of co-amoxiclav, amoxicillin and vancomycin against methicillin-resistant Staphylococcus aureus Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 12(2): 136-139
Linasmita, P. 2012: Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report Journal of the Medical Association of Thailand 95(7): 960-963
Sahuquillo Arce, J.M.; Colombo Gainza, E.; Gil Brusola, A.; Ortiz Estévez, R.; Cantón, E.; Gobernado, M. 2006: In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 19(3): 252-257
Thamlikitkul, V. 1991: Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method Journal of the Medical Association of Thailand 74(12): 669-674
Kuti, J.L.; Nicasio, A.M.; Sutherland, C.A.; Nicolau, D.P. 2009: Elevated vancomycin minimum inhibitory concentrations among methicillin-resistant Staphylococcus aureus isolated from patients with ventilator-associated pneumonia at a Connecticut hospital Connecticut Medicine 73(6): 337-340
Jaruratanasirikul, S.; Julamanee, J.; Sudsai, T.; Saengsuwan, P.; Jullangkoon, M.; Ingviya, N.; Jarumanokul, R. 2010: Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus Journal of the Medical Association of Thailand 93(2): 172-176
Rashid, Z.; Farzana, K.; Sattar, A.; Murtaza, G. 2012: Prevalence of nasal Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in hospital personnel and associated risk factors Acta Poloniae Pharmaceutica 69(5): 985-991
Pryjma, J.; Heczko, P.B.; Bóbr, J. 1971: Studies on carriers of Staphylococcus aureus. II. Ecologic equilibrium of Staphylococcus aureus and diphteroids in the anterior nasal cavity Przeglad Epidemiologiczny 25(2): 223-228